🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aggressive posterior retinopathy of prematurity (AP-ROP) is a severe form o...
Status
Completed
Location
Ainshams University
Start Date
2021-09-10
Trial ID
NCT07721298
Treatments Being Tested
The purpose of this study is to demonstrate a statistically significant imp...
Status
Unknown
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00811200
Treatments Being Tested
The aim of this study is to test if PF582 (ranibizumab) is safe and similar...
Status
Completed
Location
Eye Institute
Start Date
2013-11
Trial ID
NCT02121353
The purpose of this study is to determine the efficacy and safety of the bi...
Status
Completed
Location
Research Site
Start Date
2015-12-19
Trial ID
NCT02611778
Treatments Being Tested
In the Western World, Age Related Macular Degeneration (ARMD) is a leading ...
Status
Completed
Location
St. Joseph's Healthcare Hamilton Regional Eye Centre
Start Date
2011-03
Trial ID
NCT01243086
Treatments Being Tested
Diabetic macular edema (DME) is a sign of diabetic retinopathy that affects...
Status
Completed
Location
Minia University
Start Date
2017-01
Trial ID
NCT04087746
Treatments Being Tested
In the Western World, Age Related Macular Degeneration (ARMD) is a leading ...
Status
Unknown
Location
University Health Network-Toronto Western Hospital
Start Date
2011-01
Trial ID
NCT01249937
Treatments Being Tested
The study will assess the safety and efficacy of Everolimus (RAD001) alone ...
Status
Terminated
Location
Retina-Vitreous Associates Medical Group
Start Date
2009-02
Trial ID
NCT00857259
Treatments Being Tested
The goal of this clinical trial is to to evaluate the changes in retinal mi...
Status
Completed
Location
Ain shams university
Start Date
2023-01-01
Trial ID
NCT05861466
Treatments Being Tested
Since 2004, intravitreal injection of Avastin, Lucentis, and Macugen for we...
Status
Completed
Location
Retina Vitreous Associates of Florida
Start Date
2012-07
Trial ID
NCT01640171